alternatives to glp-1 drugs for Employers GLP-1 drugs and muscle loss:

2025;48(1 Suppl 1):S181206

We present clinical strategies for adverse event mitigation, monitoring recommendations, contraindications, and practical considerations for treatment discontinuation or switching

Wegovy and Ozempic should be stopped at least 2 months before attempting pregnancy, while Saxenda should be stopped at least 1 month before

Amelioration of diabetes mellitus by modulation of GLP-1 via targeting alpha-glucosidase using Acacia tortilis polysaccharide in Streptozotocin-Nicotinamide induced diabetes in rats

Mounjaro is FDA-approved to treat type 2 diabetes alongside diet and exercise

Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given Glucagon-Like Peptide-1 (GLP-1) receptor agonists